Search

everythinglearnresearchcommunity

for

Search:↓

Both human platelet lysate and minoxidil can promote hair growth, but they affect different genes and cell survival rates.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

BeauTop improves hair growth in androgenetic alopecia patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Enzymes play crucial roles in metabolism, health, and disease management.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Plant extracts can help prevent hair loss and promote hair growth.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Different types of skin stem cells can change and adapt, which is important for developing new treatments.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Tadalafil and Finasteride may help treat aggressive melanoma.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.